Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-01-26 09:17 am Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | BlackRock Inc. BLK | 9,825,375 17.6% | 10,778 (+0.11%) | View |
2021-02-16 5:09 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | ARMISTICE CAPITAL LLC | 5,399,277 9.8% | 2,423,277 (+81.43%) | View |
2021-02-16 4:49 pm Sale | 13G | VANDA PHARMACEUTICALS INC VNDA | Palo Alto Investors LP | 4,230,548 7.74% | -294,928 (-6.52%) | View |
2021-02-12 08:25 am Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | MACQUARIE GROUP LTD | 3,192,034 5.83% | 94,212 (+3.04%) | View |
2021-02-11 2:34 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | RENAISSANCE TECHNOLOGIES LLC | 3,990,403 7.3% | 537,291 (+15.56%) | View |
2021-02-11 08:32 am Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | STATE STREET CORP STT | 3,203,904 5.86% | 3,203,904 (New Position) | View |
2021-02-10 11:57 am Sale | 13G | VANDA PHARMACEUTICALS INC VNDA | VANGUARD GROUP INC | 3,959,080 7.24% | -501,703 (-11.25%) | View |
2021-01-25 4:49 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | BlackRock Inc. BLK | 9,814,597 17.9% | 428,716 (+4.57%) | View |
2020-02-14 4:01 pm Sale | 13G | VANDA PHARMACEUTICALS INC VNDA | Consonance Capital Management LP | 0 0% | -4,658,759 (Position Closed) | View |
2020-02-14 3:16 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | Palo Alto Investors LP | 4,525,476 8.48% | 179,905 (+4.14%) | View |
2020-02-14 11:10 am Sale | 13G | VANDA PHARMACEUTICALS INC VNDA | ARMISTICE CAPITAL LLC | 2,976,000 5.6% | -292,000 (-8.94%) | View |
2020-02-13 4:38 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | MACQUARIE GROUP LTD | 3,097,822 5.81% | 639,538 (+26.02%) | View |
2020-02-12 1:48 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | RENAISSANCE TECHNOLOGIES LLC | 3,453,112 6.47% | 3,453,112 (New Position) | View |
2020-02-12 09:23 am Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | VANGUARD GROUP INC | 4,460,783 8.36% | 296,271 (+7.11%) | View |
2020-02-04 12:30 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | BlackRock Inc. BLK | 9,385,881 17.6% | 611,539 (+6.97%) | View |
2019-06-24 4:58 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | ARMISTICE CAPITAL LLC | 3,268,000 6.2% | 3,268,000 (New Position) | View |